HPQ
57
-5
HES
57
-5
LOW
40
-2
MUR
43
-2
XOM
60
-2
QRVO
50
-2
RIG
11
-5
DVN
32
-4
HON
74
2
CTAS
49
3
NEE
67
13
AAP
48
-2
FLS
52
-3
DVA
59
3
PBI
55
10
XEL
48
2
AMGN
33
2
TMO
47
-5
PYPL
50
9
COF
72
12
HPQ
57
-5
HES
57
-5
LOW
40
-2
MUR
43
-2
XOM
60
-2
QRVO
50
-2
RIG
11
-5
DVN
32
-4
HON
74
2
CTAS
49
3
NEE
67
13
AAP
48
-2
FLS
52
-3
DVA
59
3
PBI
55
10
XEL
48
2
AMGN
33
2
TMO
47
-5
PYPL
50
9
COF
72
12
Financhill
Back

ProShares UltraShort Financials Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
12

SKF
ProShares UltraShort Financials

Last Price:
$28.03
Seasonality Move:
-5.63%
Sell
47

SRPT
Sarepta Therapeutics

Last Price:
$19.23
Seasonality Move:
37.39%
Sell
12
ProShares UltraShort Financials (SKF) is a Sell

Is ProShares UltraShort Financials a Buy, Sell or Hold?

  • The current ProShares UltraShort Financials [SKF] share price is $27.95. The Score for SKF is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
  • SKF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
47
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $19.23. The Score for SRPT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SKF Stock Price Chart

What is ProShares UltraShort Financials's stock price today?

  • The ProShares UltraShort Financials share price today is $27.95
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SKF is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $19.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight buying pressure.

SKF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.93 Buy
Relative Strength Index (14 RSI): 39.58 Sell
Chaikin Money Flow: -9941 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.95 - 30.47) Sell
Bollinger Bands (100): (29.16 - 34.9) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.67 Buy
Relative Strength Index (14 RSI): 33.14 Sell
Chaikin Money Flow: 1476404 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.86 - 32.3) Sell
Bollinger Bands (100): (26.38 - 83.98) Sell

SKF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.91 Buy
20-day SMA: 29.01 Sell
50-day SMA: 29.9 Sell
200-day SMA: 33.57 Sell
8-day EMA: 20.08 Buy
20-day EMA: 11.06 Buy
50-day EMA: 5.09 Buy
200-day EMA: 1.37 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.58 Buy
20-day SMA: 19.63 Sell
50-day SMA: 32.35 Sell
200-day SMA: 88.22 Sell
8-day EMA: 13.55 Buy
20-day EMA: 7.46 Buy
50-day EMA: 3.44 Buy
200-day EMA: 0.93 Buy

ProShares UltraShort Financials Earnings Growth & SKF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.75 per share, a decrease this year of $5.87 per share, and an increase next year of $5.35 per share.

ProShares UltraShort Financials Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):